2011
|
| Dr Andrew Kinloch |
'Immunisation with porphyromonas gingivalis enolase induces autoimmunity to mammalian α-enolase and arthritis in DR4IE transgenic mice' |
| Mrs Elizabeth Camacho |
'The association between helplessness, socioeconomic status, and disease outcome in patients with inflammatory polyarthritis' |
Ms Rebecca-Jane Law
|
'Perceptions of issues relating to exercise and joint health in rheumatoid arthritis: a UK-based questionnaire study' |
| Dr Louise Mercer |
'Risk of cancer in patients receiving non-biologic disease modifying therapy for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register (BSRBR)' |
| Dr Benjamin Schreiber |
'Diagnosis and prognosis of pulmonary arterial hypertension in SLE and SSC' |
| 2010 |
| Dr James Galloway |
'Risk of septic arthritis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSR Biologics Register (BSRBR)' |
| Dr Sarah Wythe |
'Targeting the inflamed microvasculature in rheumatoid arthritis' |
| Dr Laura Coates |
'Achieving minimal disease activity (MDA) criteria with anti-TNF therapy in psoriatic arthritis can prevent progressive joint damage' |
| Dr Luke Gompels |
'Quantifying in vivo fluorescence imaging in murine arthritis by targeting E-selectin' |
| Dr Michele Bombardieri |
'Rheumatoid synovial fibroblasts support aid expression and Ig class-switching in B cells via a BAFF-dependent TLR3-stimulated pathway' |
| Dr Louise Mercer |
'The risk of non-melanoma skin cancer in patients receiving anti-TNF therapies for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register' |
2009
|
| Dr. I Atchia |
‘Musculoskeletal ultrasound predicts response to corticosteroid injection in moderate-severe hip osteoarthritis’ |
| Dr M Bombardieri |
‘Il-23 overexpression as immunological signature of subclinical intestinal inflammation in ankylosing spondylitis’ |
| Dr E Derrett-Smith |
‘Vasculopathy in a TGF-β; dependent mouse model of systemic sclerosis’ |
| Dr S Haque |
‘Impaired endothelial progenitor cell function and early atherosclerosis in systemic lupus erythematosus (SLE)’ |
| Dr E Vital |
‘How to manage non-response to rituximab? Predictors and outcome of retreatment provide a treatment algorithm’ |
| Ms N Wegner |
‘Endogenously citrullinated proteins from porphyromonas gingivalis as a candidate source of priming autoantigens in rheumatoid arthritis’ |
2008
|
| Dr S Wright |
‘A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus’ |
| Dr V Panoulas |
‘Genetic regulation of hypertension in patients with rheumatoid arthritis’ |
Dr A Bennett
|
‘Early inflammatory back pain and mri sacroiliitis: severity of osteitis
at baseline and HLA-b27 predict ankylosing spondylitis at 8 years’ |
| Dr F Humby |
‘Activation-induced cytidine deaminase supports self sustained autoantibody production within RA synovium’ |
| Dr K Nistala |
‘Il-17-producing T cells are enriched in the joints of children with arthritis, and correlate with clinical phenotype.’ |
| Dr C L Gorman |
‘Polymorphisms in the CD3Z gene influence TCR zeta expression in healthy controls and in SLE’ |
| 2007 |
| Dr S Hamdulay |
‘Statins and rapamycin: therapeutic synergy in vascular cytoprotection’ |
| Dr S Carty |
‘Combination therapy with etanercept and SGP130 for rheumatoid arthritis is more effective than monotherapy’ |
Dr K Wartolowska
|
‘Clinical and experimental pain processing in rheumatoid arthritis patients treated with anti-TNF’
|
Dr H Chinoy
|
‘The diagnostic utility of serology testing for predicting the risk of cancer-associated myositis’
|
Dr F Barone
|
‘Aberrant expression of B cell survival factors in salivary gland’s malt lymphomas during sjögren’s syndrome’
|
Dr Z Betteridge
|
‘Anti-sumo E1: a novel autoantibody in dermatomyositis directed against the small ubiquitin-like modifier activating enzyme'
|
2006
|
Dr A El-Metwally
|
‘Risk factors for development of musculoskeletal pain in preadolescents: a prospective’
|
Dr A Judge
|
‘The effects of surgical volumes and training centre status on outcomes following total joint replacement in England’
|
Dr R Lamb
|
‘Monogenic syndromes reveal candidate loci of importance for JIA susceptibility’
|
Dr K Lundberg
|
‘Reactivity of RA sera with citrullinated-alpha-enolase peptides: development of a new diagnostic elisa’
|
Dr K E.S. Poole
|
‘A single dose of zoledronate prevents bone loss after acute stroke’
|
Dr J Prior
|
‘Studies on the potential of clinical acoustic emissions as a new assessment tool for knee arthritis’
|
2005
|
Dr E Clark
|
‘Bone mass in childhood is not related to measures of parental deprivation’
|
Dr P Ho
|
‘Psoriatic arthritis is associated with a Crohn’s disease gene’
|
Dr L Jarvis
|
‘CD8+ regulatory T cells in patients with ankylosing spondylitis (AS)’
|
Dr E Pattison
|
‘Environmental risk factors for the development of psoriatic arthritis: a case control study’
|
Dr E Smith
|
‘A novel multi-cellular model of leucocyte recruitment into the rheumatoid synovium reveals a critical role for interleukin-6’
|
Dr G Treharne
|
‘Life satisfaction and depression across 1 year with rheumatoid
arthritis: testing interactive effects of coping resources and perceived
stress’
|
2004
|
Dr K Atherton
|
‘Predicting persistence of neck pain following a motor vehicle accident:
a prospective study of persons attending emergency department’
|
Dr N Dalbeth
|
‘The angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis’
|
Dr A Kinderlerer
|
‘Upregulation of membrane-bound complement regulatory proteins by
atorvastatin protects vascular endothelium against complement-mediated
injury during hypoxia-reoxygenation’ |
| Dr P Philippidis |
‘The haemoglobin scavenger receptor CD163 mediates macrophage
interleukin-10 and haem oxygenase-1 syntheseis: an inducible
cytoprotective pathway against haemoglobin mediated oxidative vascular
injury’ |
| Dr K Raza |
‘Very early rheumatoid arthritis is characterised by a unique and transient T cell and stromal cytokine profile’ |
| Dr A Timms |
‘The IL1 gene cluster is a major locus determining susceptibility to ankylosing spondylitis’ |
2003
|
| Dr F Barone |
'CXCL13 and CCL21 play a key role in ectopic lymphogenesis in Sjögren’s Syndrome' |
| Dr M K Javaid |
'Umbilical vein calcium concentration and maternal height predict childhood bone mineral content at nine years' |
| Dr G Jones |
'Physical activity and adverse psychosocial behaviour predict the onset of widespread pain in children’ |
| Dr W Kafienah |
'Inhibition of cartilage degradation: a combine gene therapy and tissue engineering approach’ |
| Dr D O'Gradaigh |
'Cytokine-activated T-cells support osteoclastogenesis from peripheral blood mononuclear cell precursors’ |
| Dr A Lyn Tan |
'The role of metacarpophalangeal joint anatomical factors on the
distribution of synovitis and bone erosion in early rheumatoid
arthritis’ |
| 2002 |
| Dr A Afuwape |
'Adenoviral delivery of soluble VEGF receptor (sFLT-1) abrogates disease activity in murine collagen induced arthritis’ |
| Dr N Goodson |
'Cardiovascular risk factors are not increased prior to the onset of inflammatory polyarthritis’ |
| Dr E Zeggini |
'Development of tumour necrosis factor (TNF) polymorphism genotyping and
association study with juvenile idiopathic arthritis (JIA)’ |
| Dr R Jeffery |
'The -174 polymorphism of IL-6 alters transcription factor binding and
forms functionally significant allelic associations in systemic
arthritis’ |
| Dr J Newton |
'LTA-TNF halpotype studies identify additional rheumatoid arthritis susceptibility regions in the MHC’ |
| Dr C McCarthy |
'Knee classes are superior to home exercises in reducing pain and
increasing function in patients with knee osteoarthritis: results from a
randomised clinical trial’ |
2001
|
| Dr C Blades |
‘Development of a new model to investigate lymphocyte migration into
human peripheral lymph nodes (HPLN) into transplanted SCID mice’ |
| Dr M Carulli |
‘Role of BCA-1 chemokine (CK) in the organization of follicle-like structures in Rheumatoid arthritis (RA)’ |
| Dr K Walker-Bone |
‘Brawn or brain? Mechanical and psychosocial risk factors for neck and upper limb musculoskeletal disorders’ |
| Dr S Lane |
‘Is farming a risk factor for primary systemic vasculitis (PSV)?’ |
| Dr A W Morgan |
‘Linkage disequilibrium at the FC gamma receptor locus and association
of an FC gamma receptor haplocyte with rheumatoid arthritis (RA) in two
distinct ethnic groups’ |
| Dr S Richards |
‘The Kings prescription fibromyalgia intervention trial (KeepFit)’ |
2000
|
| Dr M Ali |
‘Comparison between persistent and self-limiting synovitis by analysis of gene expression’ |
| Dr F Birrell |
‘Predicting the need for total hip replacement in patients newly
presenting to primary care with hip pain; a prospective cohort study’ |
| Dr P R Colville-Nash |
‘Prostaglandin F2α produced by inducible cyclooxygenase may contribute to the resolution of inflammation’ |
| Dr L Harper |
‘Apoptosis and its importance in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis’ |
| Dr T Lawrence |
‘Inhibition of NF-B activity and MCP-1/JE release in vivo, through induction of the heat shock response’ |
| Dr M S Lillicrap |
‘The repertoire of human heat shock protein 60 responsive CD40+ T cell
clones from a healthy individual contains more than one subset’ |